A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer

作者：Akaza Hideyuki^*; Uemura Hirotsugu; Tsukamoto Taiji; Ozono Seiichiro; Ogawa Osamu; Sakai Hideki; Oya Mototsugu; Namiki Mikio; Fukasawa Satoshi; Yamaguchi Akito; Uemura Hiroji; Ohashi Yasuo; Maeda Hideki; Saito Atsushi; Takeda Kentaro; Naito Seiji

来源：International Journal of Clinical Oncology, 2016, 21(4): 773-782.

DOI：10.1007/s10147-016-0952-6

• Androgen receptor inhibitor
• Enzalutamide
• Metastatic castration-resistant prostate cancer

Trial registration: ClinicalTrials.gov NCT01284920.